ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

GANX vs HYPD // RETURN ON INVESTED CAPITAL (ROIC)

Gain Therapeutics Inc. (NASDAQ) VS. Hyperion DeFi Inc. (NASDAQ) • 15-METRIC TALLY: GANX 0 — HYPD 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GANX VS. HYPD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC GANX HYPD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 62.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 180.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 HYPD /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.0 49.4 -18.40 HYPD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $49.3M $49.7M -$407.5K HYPD /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR GANX REV HYPD REV GANX GROSS % HYPD GROSS % GANX FCF HYPD FCF
FY 2025 $52.4M $813.5K — 62.7% -$18.5M -$14.8M
FY 2024 $57.0M $57.3K — -50.0% -$18.9M -$30.3M
FY 2023 $55.2K $3.8K — — -$18.9M -$23.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GANX // BETA —
HYPD // BETA —